Our experience on the new health reimbursement system and further plans for secondary care. The author gives a short review about the steps of the health reform emphasizing the importance of initiation of performance based reimbursement which has supported to reach the aims of our reform. The results of the new reimbursement system, its practical difficulties, the actions taken to overcome them are also presented. It can be stated that no theoretical objection has been arised against the performance based reimbursement. A committee has been elected for the necessary continuous maintenance of the system. The equalization of the facilities, the reconstruction process of the hospitals, the investments financed by the World Bank loans are the conditions of the further reforms. The program "For the Healthier Nation" is the most important contribution to our health reform. Financially this program based on the "The Health Promotion Foundation".
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.
Pharmacoecon Open
January 2025
Department of Health Policy and Medical Technology Research Group, LSE Health, London School of Economics and Political Science, London, UK.
Disparities in access to oncology medicines in European Union (EU) member states can impact patient outcomes profoundly, with availability and timely access varying significantly across and within member states. This paper discusses the intersection of the new European Health Technology Assessment Regulation (HTAR), the provisions of the proposed pharmaceutical legislation and their potential impacts on access to oncology medicines across EU member states. The HTAR, seeking to standardise the clinical evaluation of new medicines, has the potential to streamline the evaluation process but also risks oversimplifying diverse national healthcare needs.
View Article and Find Full Text PDFUtilizing pharmacy technicians for medication adherence patient outreach in an ambulatory care setting.
Am J Health Syst Pharm
January 2025
Community Health Network, Indianapolis, IN, USA.
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
View Article and Find Full Text PDFEnlightening Nursing Care: A Protocol for a Multicenter Observational Study Measuring Nursing Work in Hospital Settings.
Healthcare (Basel)
January 2025
Department of Health Sciences, University of Genoa, Via A. Pastore 1, 16132 Genoa, Italy.
: Rising costs and demands for improved quality of care present complex challenges for existing healthcare systems. The strain on healthcare resources is exacerbated by the increasing complexity of patient conditions. The Diagnosis-Related Group (DRG) system classifies inpatients according to clinical and treatment criteria, controls healthcare expenditures, and ensures the sustainability of procedures.
View Article and Find Full Text PDFExperiences of Family Members and Patients with Spinal Muscular Atrophy Under the Multi-Level Medical Security System in Shanxi Province, China: A Mixed Study.
Healthcare (Basel)
January 2025
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an 710061, China.
Spinal muscular atrophy is a rare genetic disease. Nusinersen and Risdiplam, recognized as disease-modifying therapies, were included in the National Reimbursement Drug List in 2022 and 2023, respectively, in China. Policies have been implemented to enhance a multi-level medical security system, particularly for rare diseases.
View Article and Find Full Text PDFMedical insurance-related professionals' identification of the benefits of the medical insurance system in Northeast China: a cross-sectional study.
BMC Health Serv Res
January 2025
Department of Social Medicine, School of Health Management, Harbin Medical University, No.157 Baojian Road, Nangang District, Harbin, 150081, China.
Background: The identification of the benefits of the medical insurance system (IBMIS) serves as an important indicator of the effectiveness of medical insurance policy implementation and provides valuable feedback during the ongoing reform phase of the medical insurance system (MIS). This research aims to analyze the IBMIS from the perspective of medical insurance-related professionals and to identify potential associate factors with IBMIS.
Methods: In 2021, we conducted a cross-sectional questionnaire survey (n = 1829) in Heilongjiang Province, located in Northeast China, to collect data.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!